Treating Patients With Prostate Cancer During COVID-19 Era Poses New Challenges


Monica L. Baskin, PhD, addresses the biggest challenges in treating patients with prostate cancer during the COVID-19 era.

Monica L. Baskin, PhD, professor, Division of Preventive Medicine, vice chair for culture and diversity, Department of Medicine, associate director, Community Outreach and Engagement, O’Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, addresses the biggest challenges in treating patients with prostate cancer during the coronavirus disease 2019 (COVID-19) era.

The biggest challenge is moving beyond the patient’s anxiety of coming into the clinic or getting involved at healthcare facilities due to concerns of COVID-19, according to Baskin. It’s important to balance these concerns with the patient’s ongoing need for treatment.

Baskin notes that many cases in prostate cancer are slow growing, in which case patients can wait for treatment. However, some patients are reluctant to complete screening and treating due to the COVID-19 pandemic. This is a challenge for many physicians, and it is important to move forward with cancer treatment and to do so in a safe manner, Baskin concludes.

Related Videos
Video 5 - "Addressing Unmet Needs and Final Perspectives on nmCRPC"
Video 4 - "Integrating ARAMIS Trial Data and Managing Adverse Events in nmCRPC Treatment"
Video 3 - "Optimizing Treatment, Biomarkers, and Chemotherapy for Patients with nmCRPC"
Video 2 - "Addressing Risks and Challenges in the Standard of Care for Patients with nmCRPC"
Video 1 - "Overview of a 75-Year-old Patient with Non-Metastatic Castration-Resistant Prostate Cancer’s Case"
Related Content